Inhibikase Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

GlobeNewswire
2025.11.20 22:04
portai
I'm PortAI, I can summarize articles.

BOSTON and ATLANTA, Nov. 20, 2025 ( GLOBE NEWSWIRE ) -- Inhibikase Therapeutics, Inc. ( NASDAQ: IKT ) ( "Inhibikase" or "Company" ) , a clinical-stage pharmaceutical company developing therapeutics to modify the course of pulmonary arterial hypertension ( "PAH" ) , today announced that it has ...

Source: GlobeNewswire The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer